Balentine LLC Jazz Pharmaceuticals PLC Transaction History

Balentine LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$129.72 - $159.85 $55,390 - $68,255	-427 Reduced 22.5%	1,471 $234,000
Q3 2022 Oct 26, 2022	BUY	$126.59 - $161.18 $28,356 - $36,104	224 Added 13.38%	1,898 $253,000
Q2 2022 Oct 26, 2022	BUY	$141.59 - $168.66 $1,982 - $2,361	14 Added 0.84%	1,674 $261,000
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $1,982 - $2,361	14 Added 0.84%	1,674 $261,000
Q1 2022 Oct 26, 2022	SELL	$129.64 - $160.7 $1,814 - $2,249	-14 Reduced 0.84%	1,660 $258,000
Q1 2022 May 06, 2022	BUY	$129.64 - $160.7 $215,202 - $266,762	1,660 New	1,660 $258,000
Q3 2020 Nov 02, 2020	SELL	$105.46 - $144.13 $53,995 - $73,794	-512 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $478 - $609	5 Added 0.99%	512 $56,000
Q4 2019 Sep 02, 2020	BUY	$117.65 - $153.73 $59,648 - $77,941	507 New	507 $76,000
Q3 2019 Nov 15, 2019	SELL	$125.18 - $143.24 $1,126 - $1,289	-9 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $1,129 - $1,300	9 New	9 $1,000
Q1 2018 May 16, 2018	SELL	$135.59 - $157.16 $68,744 - $79,680	-507 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$142.62 - $155.6 $72,308 - $78,889	507	507 $74,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.